Search

AusCann raises $12m

AusCann Group Holdings has confirmed a $12 million capital raising to fund the development and manufacture of medical cannabis products in Australia.

AusCann told the markets today it had raised the funds through the placement of 24 million shares at 50 cents each, representing a 16 per cent discount to its five-day volume-weighted average price.

The proceeds of the raising will be used to further develop its cultivation facility in Western Australia, and progress activities in Chile with its joint venture partner DayaCann.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Register for free

Sign up here for free access to 7 articles per month + twice daily business email alerts.

CAPTCHA
Thanks! This question prevents spammers...
Image CAPTCHA
Enter the characters shown in the image.

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 28/04/17

1 year TSR5 year TSR
thAurora Labs0%0%
3rdAusCann Group Holdings5850%126%
7thAssetOwl2301%37%
91stBotanix Pharmaceuticals157%18%
230thBARD1 Life Sciences43%-22%
707 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

10/05/17
$0 Other
10/05/17
$0 Issued
10/05/17
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

191st-AssetOwl$0
192nd-Aurora Labs$0
193rd-AusCann Group Holdings$0
194th-BARD1 Life Sciences$0
195th-Botanix Pharmaceuticals$0
226 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer